Hosted by Chinese Pharmaceutical Enterprises Management Association (CPEMA) and undertaken by Healthcare Executive magazine and Hejun Consulting, the 5th Selection of Top 20 Chinese Most Competitive Listed Pharmaceutical Companies and, the Selection of Top 10 Most Worth Investing Listed Pharmaceutical Companies in 2013 recently announced the results. Fosun Pharma ranked one of Top 10 Chinese Most Worth Investing Listed Pharmaceutical Companies in 2013, among other well-known manufacturers like Yunnanbaiyao Group Co., Tasly Pharmaceutical Co. and Hengrui Pharmaceutical Co. This is for the fourth time the company has received the award after the former three in 2009, 2010 and 2011 successively.

The evaluation of Top 10 Chinese Most Worth Investing Listed Pharmaceutical Companies in 2013 is based primarily on the recommendations and voting by industrial experts, senior pharmaceutical securities analysts, institutional investors and pharmaceutical industry financial reporters. The final names on the list, as pioneers in all fields of the pharmaceutical industry, are definitely leaders in the overall development of the pharmaceutical sector.